Minerva Neurosciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1 | -1 | ||
EBITDA | 17,466 | -125,404 | -283,666 | -2,742 |
EBIT | -283,667 | -2,743 | ||
Net Income | 17,466 | -125,404 | -283,667 | -2,743 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -13,344,821 | -5,427,064 | -4,480 | -2,916 |
Cash | 24,652 | 32,759 | 82,301 | 12,286 |
Basic Shares | 79,104 | 43,900 | 11,118 | 7,569 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -5 | -22 | -30 | -8 |
EBITDA | -293,417 | 6,023 | -21,691 | -24,693 |
EBIT | -293,423 | 6,001 | -21,722 | -24,702 |
Net Income | -293,423 | 1,438 | -30,005 | -32,108 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -13,510,936 | -19,550 | -14,784 | -24,661 |
Cash | 82,302 | 21,362 | 40,912 | 36,093 |
Basic Shares | 8,464 | 7,574 | 6,506 | 5,340 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.46 |
2026-03-31 | -$0.17 |
2025-12-31 | -$25.51 |
2025-09-30 | -$0.36 |